Publications

Tailoring immunisation programmes: Using behavioural insights to identify barriers and enablers to childhood immunisations in a Jewish community in London, UK.

Letley, L; Rew, V; Ahmed, R; Habersaat, KB; PATERSON, P; CHANTLER, T; Saavedra-Campos, M; Butler, R;

2018

Vaccine, (2018).36 31 10.1016/j.vaccine.2018.06.028.

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries.

GALLAGHER, KE; KELLY, H; Cocks, N; Dixon, S; MOUNIER-JACK, S; HOWARD, N; WATSON-JONES, D;

2018

Papillomavirus research (Amsterdam, Netherlands), (2018).6, 10.1016/j.pvr.2018.10.004.

Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during Mycobacterium tuberculosis Infection and Disease.

Garand, M; GOODIER, M; Owolabi, O; Donkor, S; KAMPMANN, B; SUTHERLAND, JS;

2018

Frontiers in immunology, (2018).9 FEB 10.3389/fimmu.2018.00257.

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.

Toh, ZQ; Cheow, KW B; Russell, FM; Hoe, E; Reyburn, R; Fong, J; Tuivaga, E; Ratu, FT; Nguyen, CD; Matanitobua, S; Reitsma, A; Tabrizi, SN; Garland, SM; MULHOLLAND, EK; Licciardi, PV;

2018

Open forum infectious diseases, (2018).5 7 10.1093/ofid/ofy147.

Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development.

Benavente, ED; Oresegun, DR; De Sessions, PF; WALKER, EM; ROPER, C; Dombrowski, JG; De Souza, RM; Marinho, CR F; SUTHERLAND, CJ; HIBBERD, ML; Mohareb, F; BAKER, DA; CLARK, TG; CAMPINO, S;

2018

Scientific reports, (2018).8 1 10.1038/s41598-018-33767-3.

Vaccination to reduce antimicrobial resistance.

ATKINS, KE; FLASCHE, S;

2018

The Lancet Global health, (2018).6 3 10.1016/S2214-109X(18)30043-3.

Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.

Temple, B; Toan, NT; Uyen, DY; Balloch, A; Bright, K; Cheung, YB; Licciardi, P; Nguyen, CD; Phuong, NT M; Satzke, C; Smith-Vaughan, H; Vu, TQ H; Huu, TN; MULHOLLAND, EK;

2018

BMJ open, (2018).8 6 10.1136/bmjopen-2017-019795.

Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.

Kimaro Mlacha, SZ; Warira, A; Gatakaa, H; Goldblatt, D; SCOTT, JA G;

2018

Scientific reports, (2018).8 1 10.1038/s41598-018-33735-x.

Informing development strategies for new tuberculosis vaccines: mathematical modelling and novel epidemiological tools.

HARRIS, R;

2018

(2018). 10.17037/PUBS.04648987.

HIV, HCMV and mycobacterial antibody levels: a cross-sectional study in a rural Ugandan cohort.

Stockdale, L; NASH, S; NALWOGA, A; GIBSON, L; PAINTER, H; RAYNES, J; Asiki, G; NEWTON, R; FLETCHER, H;